oa SA Pharmaceutical Journal - Hypercholesterolaemia : from inauspicious to appropriate to detrimental : case study



Hypercholesterolaemia is a chronic disease that affects up to 53% of the global population. Lifestyle modification and early diagnosis plays an important role in the management of this condition. Various cholesterol screening tests are available, and it is generally accepted that a fasting finger-prick cholesterol test administered by the local pharmacist or primary healthcare provider should not exceed a value of 4.9 mmol/l. However, these screening tests measure the amount of total cholesterol (TC), and rarely differentiate between the individual lipoprotein components. Target values for the different cholesterol components have been well established.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error